These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12182916)

  • 21. Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography.
    Karlsson G; Winge S
    Protein Expr Purif; 2004 Feb; 33(2):339-45. PubMed ID: 14711523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential role of fractionated heparin in antithrombin-III proteolysis.
    Marciniak E
    Blood; 1982 Mar; 59(3):576-81. PubMed ID: 7037067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anticoagulant activation of antithrombin by heparin.
    Jin L; Abrahams JP; Skinner R; Petitou M; Pike RN; Carrell RW
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14683-8. PubMed ID: 9405673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: Importance of low heparin affinity.
    Azhar A; Khan MS; Swaminathan A; Naseem A; Chatterjee S; Jairajpuri MA
    Int J Biol Macromol; 2016 Jan; 82():541-50. PubMed ID: 26554332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.
    Aiach M; François D; Priollet P; Capron L; Roncato M; Alhenc-Gelas M; Fiessinger JN
    Br J Haematol; 1987 Aug; 66(4):515-22. PubMed ID: 3663508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pasteurization of antithrombin without generation of the prelatent form of antithrombin.
    Karlsson G
    Protein Expr Purif; 2004 Jun; 35(2):381-6. PubMed ID: 15135417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the biological activity of antithrombin III in patients with hepatic cirrhosis.
    Matsuo T; Matsuo C; Matsuo O
    Clin Chim Acta; 1984 Jul; 140(2):125-32. PubMed ID: 6467606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glycosylation on heparin binding and antithrombin activation by heparin.
    Pol-Fachin L; Franco Becker C; Almeida Guimarães J; Verli H
    Proteins; 2011 Sep; 79(9):2735-45. PubMed ID: 21769943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of functionally active human antithrombin III.
    Stephens AW; Siddiqui A; Hirs CH
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3886-90. PubMed ID: 3473488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparative conversion of native human antithrombin to the latent form.
    Karlsson G; Winge S
    Protein Expr Purif; 2002 Oct; 26(1):106-10. PubMed ID: 12356477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capillary affinity chromatography and affinity capillary electrophoresis of heparin binding proteins.
    Wu X; Linhardt RJ
    Electrophoresis; 1998 Nov; 19(15):2650-3. PubMed ID: 9848674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidation of methionine residues in antithrombin. Effects on biological activity and heparin binding.
    Van Patten SM; Hanson E; Bernasconi R; Zhang K; Manavalan P; Cole ES; McPherson JM; Edmunds T
    J Biol Chem; 1999 Apr; 274(15):10268-76. PubMed ID: 10187813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single-step method for the isolation of antithrombin III.
    Wickerhauser M; Williams C
    Vox Sang; 1984; 47(6):397-405. PubMed ID: 6516292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.